Equities

BioMaxima SA

BioMaxima SA

Actions
  • Price (EUR)2.76
  • Today's Change-0.06 / -2.13%
  • Shares traded--
  • 1 Year change-17.24%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 14:29 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of PLN
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1.50133.01
Total Receivables, Net8.561017
Total Inventory131314
Prepaid expenses------
Other current assets, total----0
Total current assets233634
Property, plant & equipment, net513828
Goodwill, net------
Intangibles, net0.370.440.50
Long term investments000.01
Note receivable - long term------
Other long term assets------
Total assets747462
LIABILITIES
Accounts payable5.457.396.72
Accrued expenses------
Notes payable/short-term debt008.14
Current portion long-term debt/capital leases3.801.720.51
Other current liabilities, total1.191.871.98
Total current liabilities101117
Total long term debt9.064.118.62
Total debt135.8317
Deferred income tax0.330.770.53
Minority interest--00
Other liabilities, total6.976.116.24
Total liabilities272233
SHAREHOLDERS EQUITY
Common stock4.194.334.32
Additional paid-in capital------
Retained earnings (accumulated deficit)334315
Treasury stock - common0(5)--
Unrealized gain (loss)------
Other equity, total9.849.849.84
Total equity475229
Total liabilities & shareholders' equity747462
Total common shares outstanding4.194.334.32
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.